128 related articles for article (PubMed ID: 9062397)
1. Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA.
Nilsson O; Peter A; Andersson I; Nilsson K; Grundström B; Karlsson B
Br J Cancer; 1997; 75(6):789-97. PubMed ID: 9062397
[TBL] [Abstract][Full Text] [Related]
2. Characterization of antibodies to prostate-specific antigen.
Nilsson O; Andersson I; Peter A; Karlsson B
Tumour Biol; 1999; 20 Suppl 1():43-51. PubMed ID: 10628409
[TBL] [Abstract][Full Text] [Related]
3. Characterization of novel monoclonal antibodies for prostate-specific antigen (PSA) with potency to recognize PSA bound to alpha 2-macroglobulin.
Baumgart Y; Otto A; Schäfer A; Usbeck E; Cott C; Schott A; Tornack M; Wenzel A; Mossie A; Birkenmeier G
Clin Chem; 2005 Jan; 51(1):84-92. PubMed ID: 15528296
[TBL] [Abstract][Full Text] [Related]
4. Generation of PSA-ACT-specific monoclonal antibodies and their application in a sandwich immunoassay.
Wang TJ; Linton HJ; Payne J; Rittenhouse HG; Chan DW; Partin AW; Wolfert RL; Kuus-Reichel K
Hybridoma; 1999 Dec; 18(6):535-41. PubMed ID: 10626683
[TBL] [Abstract][Full Text] [Related]
5. Epitope analysis of a prostate-specific antigen (PSA) C-terminal-specific monoclonal antibody and new aspects for the discrepancy between equimolar and skewed PSA assays.
Nagasaki H; Watanabe M; Komatsu N; Kaneko T; Dubé JY; Kajita T; Saitoh Y; Ohta Y
Clin Chem; 1999 Apr; 45(4):486-96. PubMed ID: 10102908
[TBL] [Abstract][Full Text] [Related]
6. Characterization of 10 new monoclonal antibodies against prostate-specific antigen by analysis of affinity, specificity and function in sandwich assays.
Corey E; Wegner SK; Stray JE; Corey MJ; Arfman EW; Lange PH; Vessella RL
Int J Cancer; 1997 Jun; 71(6):1019-28. PubMed ID: 9185706
[TBL] [Abstract][Full Text] [Related]
7. Characterization of monoclonal antibodies for prostate-specific antigen and development of highly sensitive free prostate-specific antigen assays.
Black MH; Grass CL; Leinonen J; Stenman UH; Diamandis EP
Clin Chem; 1999 Mar; 45(3):347-54. PubMed ID: 10053035
[TBL] [Abstract][Full Text] [Related]
8. Summary report of the TD-3 workshop: characterization of 83 antibodies against prostate-specific antigen.
Stenman UH; Paus E; Allard WJ; Andersson I; Andrès C; Barnett TR; Becker C; Belenky A; Bellanger L; Pellegrino CM; Børmer OP; Davis G; Dowell B; Grauer LS; Jette DC; Karlsson B; Kreutz FT; van der Kwast TM; Lauren L; Leinimaa M; Leinonen J; Lilja H; Linton HJ; Nap M; Hilgers J
Tumour Biol; 1999; 20 Suppl 1():1-12. PubMed ID: 10628402
[TBL] [Abstract][Full Text] [Related]
9. Epitope mapping of 53 antibodies against prostate-specific antigen.
Bellanger L; Andrès C; Seguin P
Tumour Biol; 1999; 20 Suppl 1():18-23. PubMed ID: 10628404
[TBL] [Abstract][Full Text] [Related]
10. Characterization of epitope structure for 53 monoclonal antibodies against prostate-specific antigen.
Becker C; Wigheden I; Lilja H
Tumour Biol; 1999; 20 Suppl 1():13-7. PubMed ID: 10628403
[TBL] [Abstract][Full Text] [Related]
11. Anti-free prostate-specific antigen monoclonal antibody epitopes defined by mimotopes and molecular modeling.
Michel S; Deléage G; Charrier JP; Passagot J; Battail-Poirot N; Sibai G; Jolivet M; Jolivet-Reynaud C
Clin Chem; 1999 May; 45(5):638-50. PubMed ID: 10222350
[TBL] [Abstract][Full Text] [Related]
12. Epitope mapping and affinity estimation of 83 antibodies against prostate-specific antigen.
Paus E; Nustad K; Børmer OP
Tumour Biol; 1999; 20 Suppl 1():52-69. PubMed ID: 10628410
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen: characterization of epitopes by synthetic peptide mapping and inhibition studies.
Corey E; Wegner SK; Corey MJ; Vessella RL
Clin Chem; 1997 Apr; 43(4):575-84. PubMed ID: 9105257
[TBL] [Abstract][Full Text] [Related]
14. Epitope mapping of prostate-specific antigen with monoclonal antibodies.
Jette DC; Kreutz FT; Malcolm BA; Wishart DS; Noujaim AA; Suresh MR
Clin Chem; 1996 Dec; 42(12):1961-9. PubMed ID: 8969633
[TBL] [Abstract][Full Text] [Related]
15. Reactivity of 77 antibodies to prostate-specific antigen with isoenzymes and complexes of prostate-specific antigen.
Leinonen J; Zhang WM; Paus E; Stenman UH
Tumour Biol; 1999; 20 Suppl 1():28-34. PubMed ID: 10628406
[TBL] [Abstract][Full Text] [Related]
16. Analysis of prostate specific antigen and alpha1-antichymotrypsin interaction using antipeptide monoclonal antibodies.
Michel S; Charrier JP; Deleage G; Battail-Poirot N; Jolivet M; Jolivet-Reynaud C
J Urol; 2001 Jan; 165(1):301-6. PubMed ID: 11125429
[TBL] [Abstract][Full Text] [Related]
17. Three immunoassays based on monoclonal antibodies specific for prostate specific antigen (PSA), alpha-1-antichymotrypsin (ACT), and the PSA-ACT complex.
Wan XS; Xu YA; Ware JH; Kennedy AR
Prostate; 2003 Jul; 56(2):131-41. PubMed ID: 12746838
[TBL] [Abstract][Full Text] [Related]
18. A highly sensitive enzyme-linked immunoassay for serum free prostate specific antigen (f-PSA).
Matsumoto K; Konishi N; Hiasa Y; Kimura E; Takahashi Y; Shinohara K; Samori T
Clin Chim Acta; 1999 Mar; 281(1-2):57-69. PubMed ID: 10217627
[TBL] [Abstract][Full Text] [Related]
19. Western blotting analysis of antibodies to prostate-specific antigen: cross-reactivity with human kallikrein-2.
Wang TJ; Linton HJ; Rittenhouse HG; Wolfert RL
Tumour Biol; 1999; 20 Suppl 1():75-8. PubMed ID: 10628412
[TBL] [Abstract][Full Text] [Related]
20. Characterization of monoclonal antibodies against prostate specific antigen produced by genetic immunization.
Leinonen J; Niemelä P; Lövgren J; Bocchi L; Pettersson K; Nevanlinna H; Stenman UH
J Immunol Methods; 2004 Jun; 289(1-2):157-67. PubMed ID: 15251421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
